Omeros Corporation 5.25% 15-FEB-2026Omeros Corporation 5.25% 15-FEB-2026Omeros Corporation 5.25% 15-FEB-2026

Omeros Corporation 5.25% 15-FEB-2026

No trades
See on Supercharts

OMER5029812 analysis



Key facts


Issue date
Aug 14, 2020
Maturity date
Feb 15, 2026
Outstanding amount
‪97.86 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
5.25% (Fixed)
Yield to maturity
28.72%
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.